INSACOG calls for Covid vaccine booster dose to those at-risk, above 40 yrs
Earlier on Thursday, the Serum Institute of India (SII) has sought India's drug regulator's approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccine in the country
Earlier on Thursday, the Serum Institute of India (SII) has sought India's drug regulator's approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccine in the country https://ift.tt/3Ih0Cfa December 02, 2021 at 10:35PM
Earlier on Thursday, the Serum Institute of India (SII) has sought India's drug regulator's approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccine in the country https://ift.tt/3Ih0Cfa December 02, 2021 at 10:35PM
Comments
Post a Comment